Deletion of the IKZF1 gene encoding the transcription factor IKAROS is observed in 15–20% of children with B-ALL and it is reported to be associated with inferior clinical outcome with a range of different treatment protocols [27, 44–47]. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.